Glaukos Corporation Announces First Quarter 2019 Financial Results
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
Pharmaceuticals, Biotechnology and Life Sciences
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization…
– Conference call and webcast today at 4:30 p.m. ET – NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology…
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology…
-Company to Hold Conference Call Today at 4:30 PM ET- WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24TTPH&src=ctag" target="_blank"gt;$TTPHlt;/agt; lt;a href="https://twitter.com/hashtag/antibioticresistance?src=hash" target="_blank"gt;#antibioticresistancelt;/agt;–Tetraphase Pharmaceuticals, Inc.…
Columbia Care to partner with experts at Montefiore Medical Center and Albert Einstein College of Medicine for initial phase of…
Potential FDA approval of AR101 for peanut allergy expected by late January 2020; Company on target to be launch-ready in…
LAVAL, Québec–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Altasciences?src=hash" target="_blank"gt;#Altascienceslt;/agt;–Altasciences won in the Most Successful Early Phase Research (Preclinical & Phase I) category at the…
DUBLIN–(BUSINESS WIRE)–The “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors – Pipeline Insights, 2019” drug pipelines has been added to ResearchAndMarkets.com’s…
DUBLIN–(BUSINESS WIRE)–The “Klebsiella Pneumoniae Infections – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers…